Following an application from Valio Ltd submitted pursuant to Article 14(1)(a) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of Lactobacillus helveticus fermented Evolus® low-fat milk products on arterial stiffness (Question No EFSA-Q-2008-218) [The EFSA Journal (2008) 824, 1-2.]. The claim proposed by the applicant was worded as follows: ‘Evolus® reduces arterial stiffness’.
Recital 25, Commission Regulation (EC) No 983/2009 of 21 October 2009 on the authorisation and refus…
In forcesince 21 Oct 2009